For adults with obesity, what are the benefits and harms of semaglutide compared with placebo?

View at publisher
Authors: Amin Sharifan
Cited by: 0
References: 1

Fields of Study & Subjects

Pharmacology and Obesity Treatment Diabetes Treatment and Management Bariatric Surgery and Outcomes

Publication details

Journal / source
Cochrane Clinical Answers
Publication date
6 February 2026
Language
EN